EXCLUSIVE: Co-Diagnostics Announces Successful Proof of Concept for Extraction-Free Ebola Test
Co-Diagnostics Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale; May Offer And Sell Up To $7.90M Of Common Stock
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin
EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform
Co-Diagnostics Announces Delegation Visit From CoMira Diagnostics At Co. Headquarters In Salt Lake City; Unveils Future Automated Production Line At Technology, Innovation Event
Co-Diagnostics Enters Into Exclusive Distribution Agreement With Partner In Mexico For Co-Dx PCR Point-Of-Care Platform
Co-Diagnostics Advances Dual Ebola PCR Testing Program To Enhance Outbreak Detection And Surveillance In Africa
Co-Diagnostics Advances Its PCR Assay Development Strategy For The Bundibugyo Virus, Aided By Cosara Diagnostics JV
What's Going On With Co-Diagnostics Stock Wednesday?
Co-Diagnostics Inc (NASDAQ:CODX) Shares Fall 10% After Q1 2026 Revenue and Earnings Miss Estimates
Co-Diagnostics, Inc. (CODX) Q1 2026 Earnings Call Transcript
Co-Diagnostics Q1 2026 Earnings Call Transcript
Co-Diagnostics Files Prospectus To Offer And Sell Up To $150M In Securities
Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City
Co-Diagnostics Announces That Its JV CoMira Diagnostics Finalized A Lease Agreement For Its Planned Manufacturing Facility In Saudi Arabia
GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match Estimates
Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.